載入...
Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
Breast cancer is a heterogeneous disease, at both an inter- and intra-tumoural level. Appreciating heterogeneity through the application of biomarkers and molecular signatures adds complexity to tumour taxonomy but is key to personalising diagnosis, treatment and prognosis. The extent to which heter...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4800308/ https://ncbi.nlm.nih.gov/pubmed/26996207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep23383 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|